ScholarIQanswers from OpenAlex

Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer

PaperCitations, authors & open-access status

Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer have?

ScholarIQcitation count

Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer published?

ScholarIQyear

Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer has 2023 year in the ScholarIQ index.

What is the open-access status of Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer?

ScholarIQoa status

Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer has diamond oa status in the ScholarIQ index.

What is the DOI of Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer?

ScholarIQdoi

The DOI for Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer is on the source record.

What is the OpenAlex record for Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer?

ScholarIQopenalex

The OpenAlex for Epidermal growth factor receptor expression and adjuvant chemoradiotherapy in rectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial